Hormonal contraceptives linked to increased risk of postpartum depressionA Danish study suggests that the use of certain hormonal contraceptives after childbirth may increase the risk of postpartum depression in first-time mothers. Hydroxychloroquine safety when used to treat rheumatic diseasesCanadian Rheumatology Association updates information on ocular toxicity monitoring and provides reassurance on cardiac safety at usual rheumatologic therapeutic doses. Health Canada recalls Life Brand Melatonin, Riva Acetaminophen for dosage concerns Health Canada says in both releases the recalled products were distributed nationally. Six new drug indications doctors and pharmacists need to know about Get the info you need on these new indications, part of our drug news roundup for April. New Health Canada advisory: GLP-1 RAs and suicide risk Get the info you need on this new Health Canada advisory, part of our drug news roundup for April. New dosage form: Mounjaro KwikPen Get the info you need on this new dosage form, part of our drug news roundup for April. NEW DRUG: Vyloy Get the info you need on this new drug, part of our drug news roundup for April. Not just a bit of ‘chemobrain’: Barriers persist to treating cancer-related cognitive impairment Urgent need for a tailored screening panel for patients with CRCI, as typical formal neurocognitive testing was developed for very different situations. Three new generics pharmacists and physicians should know about Get the info you need on these new generics, part of our drug news roundup for April. NEW DRUG: Steqeyma/Steqeyma I.V. Get the info you need on this new drug, part of our drug news roundup for April. First Previous 22 23 24 25 26 Next Last
